In this context, the abovementioned inflamma-miR miR-146a, with increased levels reported in SS, targets and regulates NF-kB levels through inhibition of IRAK1 and TRAF6, and blocks the pro-inflammatory signal to restore basal levels [183]. This evidence concerns the gene TRAF6 and synovial sarcoma.